PHARMAC | New Zealand Government - Te Pātaka Whaioranga
News and latest updates
-
From 1 February 2021 pre-COVID-19 Special Authority criteria will be reinstated
Roll back of changes made to funding requirements to support the COVID-19 response.
12 January 2021
-
Decision to widen access to valganciclovir for transplant patients
From 1 February 2021
12 January 2021
-
Oral contraceptives
Norimin and Brevinor 1/28 are resupplied
15 January 2021
About PHARMAC | Mō Te Pātaka Whaioranga
- Our purpose is to deliver the best health outcomes from the Government’s investment in medicines and medical devices.
- We promote the responsible use of medicines in New Zealand. This means making sure medicines are not under-used, over-used or misused.
- Te Pātaka Whaioranga, ‘the storehouse of wellbeing’, sums up the part we play in managing and safeguarding something that is valuable to our whole community – the pursuit of wellbeing.
- We negotiate national contracts for hospital medical devices. In the future, we'll decide which medical devices are available for public hospitals.
Have your say on our funding decisions
We ask for your feedback on our decisions to fund a medicine or related product. We want to know what impact funding that medicine will have on prescribers, pharmacists and people who take the medicine.
Contact us
Talk to our enquiries team. We're ready to answer your questions about funded medicines and related products.
Year in Review 2020
Read about the difference we made to New Zealanders lives in 2020.